The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
A correction has been published: N Engl J Med 2001;344(5):392.

Original Article
Volume 342:673-680 March 9, 2000 Number 10
NextNext

Clinical and Genetic Features of Ehlers–Danlos Syndrome Type IV, the Vascular Type
Melanie Pepin, M.S., Ulrike Schwarze, M.D., Andrea Superti-Furga, M.D., and Peter H. Byers, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Editorial
 by Pyeritz, R. E.
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
-PubMed Citation
ABSTRACT

Background Ehlers–Danlos syndrome type IV, the vascular type, results from mutations in the gene for type III procollagen (COL3A1). Affected patients are at risk for arterial, bowel, and uterine rupture, but the timing of these events, their frequency, and the course of the disease are not well documented.

Methods We reviewed the clinical and family histories of and medical and surgical complications in 220 index patients with biochemically confirmed Ehlers–Danlos syndrome type IV and 199 of their affected relatives. We identified the underlying COL3A1 mutation in 135 index patients.

Results Complications were rare in childhood; 25 percent of the index patients had a first complication by the age of 20 years, and more than 80 percent had had at least one complication by the age of 40. The calculated median survival of the entire cohort was 48 years. Most deaths resulted from arterial rupture. Bowel rupture, which often involved the sigmoid colon, accounted for about a quarter of complications but rarely led to death. Complications of pregnancy led to death in 12 of the 81 women who became pregnant. The types of complications were not associated with specific mutations in COL3A1.

Conclusions Although most affected patients survive the first and second major complications, Ehlers–Danlos syndrome type IV results in premature death. The diagnosis should be considered in young people who come to medical attention because of uterine rupture during pregnancy or arterial or visceral rupture.


Source Information

From the Departments of Pathology (M.P., U.S., P.H.B.) and Medicine (P.H.B.), University of Washington, Seattle; and the Division of Metabolic and Molecular Diseases, Department of Pediatrics, University of Zurich, Zurich, Switzerland (A.S.-F.).

Address reprint requests to Dr. Byers at the Department of Pathology, Box 357470, University of Washington, Seattle, WA 98195-7470, or at pbyers{at}u.washington.edu.

Full Text of this Article


Related Letters:

Ehlers–Danlos Syndrome Type IV
Barabas A. P., Pinto Y. M., Pals G., Zijlstra J. G., Tulleken J. E., Byers P. H., Schwarze U., Pepin M., Pyeritz R. E.
Extract | Full Text  
N Engl J Med 2000; 343:366-368, Aug 3, 2000. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.